AzTrials
AzTrials

Dysmenorrhea PrimaryNCT04852627

Effect of Brisk Walking on Primary Dysmenorrhea

A study testing Brisk walking in people with Dysmenorrhea Primary, run by Ain Shams University at 1 site in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Dysmenorrhea is a common problem in women. Exercise is commonly cited as a possible remedy. We will measure the effect of brisk walking on primary dysmenorrhea among medical students. Read more about this study

Who is it for?
Ages 17 to 25 years, women onlyHealthy volunteers can take part
Conditions the study is for
Dysmenorrhea Primary
What is being tested?
Brisk walking
Could I receive a placebo?
No, everyone receives an active treatment
How many people
170 participants
Where
1 siteEgypt
Study dates
24 Apr 2021to 20 May 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 17 to 25 years
  • Women only
  • Healthy volunteers accepted
  • Child, Adult

Who may be able to join

  • BMI: 18-25
  • regular menstrual cycles

Who cannot join

  • Marriage or previous sexual activity
  • medical disorders
  • previous abdominal or pelvic surgery
  • skeletal disorders
  • hormonal or psychiatric treatment
  • atheletes

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • AinShams Maternity Hospital

    Cairo, 002

Other trials in Egypt

About this study

Official title: Effect of Brisk Walking on Primary Dysmenorrhea Among Medical Students

Dysmenorrhea is a common problem in women. Exercise is commonly cited as a possible remedy. We will measure the effect of brisk walking on primary dysmenorrhea among medical students.

Being tested
Brisk walking

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Brisk walkingBehavioural

    Walking

Study groups in NCT04852627
Study groupRoleWhat they receive
Exercise groupActive comparatorWill brisk walk 30 minutes 3 times weekly
Receives: Behavioral: Brisk walking
Control groupNo interventionNo intervention

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Dysmenorrhea score

    WaLIDD (working ability, location, intensity, days of pin, dysmenorrhea)score for dysmenorrhea. Least is 0, highest is 12. The higher the score, the worse dysmenorrhea

    Measured: 3 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Apr 2021
  2. Study start24 Apr 2021
  3. Primary completion12 Feb 2022
  4. Study completion20 May 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
170 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04852627
Sponsor's protocol ID
M D 59/2021
Status last verified
Sep 2022
First submitted
17 Apr 2021
Last updated
7 Sep 2022
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: IPD will be available with the principal investigator and will be shared if requested

Questions about this trial

What is this clinical trial studying?

A study testing Brisk walking in people with Dysmenorrhea Primary, run by Ain Shams University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 7 Sep 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Dysmenorrhea score (time frame: 3 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Sep 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in